» Articles » PMID: 24018050

RIO Kinase 3 Acts As a SUFU-dependent Positive Regulator of Hedgehog Signaling

Overview
Journal Cell Signal
Date 2013 Sep 11
PMID 24018050
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Suppressor of fused (SUFU) is an essential negative regulator of the mammalian Hedgehog (HH) signaling pathway and its loss is associated with cancer development. On a cellular level, endogenous SUFU can mainly be detected in the cytoplasm and the nucleus. However, immunostaining of pancreatic cancer specimen revealed the existence of cell types showing selective enrichment of endogenous SUFU in the nucleus. Following up on this observation, we found that a SUFU construct which was experimentally tethered exclusively to the nucleus was unable to antagonize endogenous HH signaling, in contrast to control SUFU. These data suggest that alterations in the normal subcellular distribution of SUFU might interfere with its established negative role on the HH pathway. Performing a multi-well kinase screen in human cells identified RIO kinase 3 (RIOK3) as a novel modulator of SUFU subcellular distribution. Functionally, RIOK3 acts as a SUFU-dependent positive regulator of HH signaling. Taken together, we propose that factors modulating the nucleo-cytoplasmic distribution of SUFU impact on the normal function of this tumor suppressing protein.

Citing Articles

WNT5A, β‑catenin and SUFU expression patterns, and the significance of microRNA deregulation in placentas with intrauterine growth restriction.

Sola I, Karin-Kujundzic V, Paic F, Lijovic L, Glibo M, Serman N Mol Med Rep. 2022; 27(2).

PMID: 36524356 PMC: 9813565. DOI: 10.3892/mmr.2022.12914.


A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker.

Li J, Sun R, He L, Sui G, Di W, Yu J Am J Transl Res. 2022; 14(6):3750-3768.

PMID: 35836879 PMC: 9274588.


Ttc30a affects tubulin modifications in a model for ciliary chondrodysplasia with polycystic kidney disease.

Getwan M, Hoppmann A, Schlosser P, Grand K, Song W, Diehl R Proc Natl Acad Sci U S A. 2021; 118(39).

PMID: 34548398 PMC: 8488674. DOI: 10.1073/pnas.2106770118.


Riok3 inhibits the antiviral immune response by facilitating TRIM40-mediated RIG-I and MDA5 degradation.

Shen Y, Tang K, Chen D, Hong M, Sun F, Wang S Cell Rep. 2021; 35(12):109272.

PMID: 34161773 PMC: 8363743. DOI: 10.1016/j.celrep.2021.109272.


LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.

Xu F, Li H, Hu C Biosci Rep. 2019; 39(7).

PMID: 31127025 PMC: 6614576. DOI: 10.1042/BSR20180551.